|
市場調査レポート
商品コード
1671852
心房細動市場：タイプ別、治療法別、技術別、エンドユーザー別、地域別Atrial Fibrillation Market, By Type, By Treatment, By Technology, By End User, By Geography |
||||||
カスタマイズ可能
|
|||||||
| 心房細動市場：タイプ別、治療法別、技術別、エンドユーザー別、地域別 |
|
出版日: 2025年02月26日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
心房細動の世界市場規模は2025年に264億3,000万米ドルと推定され、2032年には435億7,000万米ドルに達すると予測され、2025年から2032年までのCAGRは7.4%で推移すると予測されます。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年の市場規模 | 264億3,000万米ドル |
| 実績データ | 2020年から2024年まで | 予測期間 | 2025年から2032年 |
| 予測期間：2025年～2032年 CAGR： | 7.40% | 2032年の価値予測 | 435億7,000万米ドル |
心房細動は世界的に最も一般的な不整脈であり、診断例の有病率は急速に増加しています。高齢者人口の増加、心血管疾患および生活習慣病の罹患率の増加、侵襲的心臓手術の増加、診断および治療デバイスの技術進歩は、この市場の成長を促進する主な要因の一部です。しかし、心房細動の診断と治療に伴う血栓塞栓症のリスクや発展途上国における心房細動に対する認識不足が市場の成長を妨げると予想されます。
市場力学：
世界の心房細動市場の成長を促進する主な要因は、心房細動に罹患しやすい老年人口の急増、肥満と高血圧の有病率の上昇、アルコールとタバコの消費量の増加、侵襲的心臓手術の増加です。しかし、心房細動の診断と治療に伴う血栓塞栓症のリスクの高さ、新興諸国における心房細動に対する認識不足が市場成長の妨げになると予測されます。新規アブレーション技術開発の研究開発と革新的ソリューションを提供する新興企業の出現は、今後数年間に大きな機会をもたらします。
本調査の主な特徴
本レポートでは、世界の心房細動市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
世界の心房細動市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
本調査の対象となる主要企業には、Pfizer Inc.、Boehringer Ingelheim GmbH、Bristol-Myers Squibb Company、Johnson &Johnson、Abbott Laboratories、Boston Scientific Corporation、Medtronic plc、AtriCure, Inc.、Sanofi、Bayer AG、Gilead Sciences, Inc.、Amgen Inc.、Merck &Co.
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
心房細動の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。
利害関係者は、世界の心房細動市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
第3章 市場力学、規制、動向分析
- 市場力学
- 促進要因
- 抑制要因
- 機会
- 影響分析
- 主な発展
- 規制シナリオ
- 製品の発売/承認
- PEST分析
- PORTERの分析
- 合併と買収のシナリオ
- 業界動向
第4章 世界の心房細動市場、タイプ別、2020年～2032年
- 発作性心房細動
- 持続性心房細動
- 永続性心房細動
第5章 世界の心房細動市場、治療法別、2020年～2032年
- 薬物療法
- 非薬物療法
第6章 世界の心房細動市場、技術別、2020年～2032年
- 無線周波数
- レーザ
- 凍結療法
- その他
第7章 世界の心房細動市場、エンドユーザー別、2020年～2032年
- 病院
- 心臓センター
- ホームケア設定
- その他
第8章 世界の心房細動市場、地域別、2020年～2032年
- 北米
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
- アフリカ
第9章 競合情勢
- Pfizer Inc.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Johnson & Johnson
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- AtriCure, Inc.
- Sanofi
- Bayer AG
- Gilead Sciences, Inc.
- Amgen Inc.
- Merck & Co., Inc.
- Jude Medical, Inc.
- Cardiovascular Systems, Inc.
第10章 アナリストの推奨事項
- 運命の輪
- アナリストの見解
- 一貫した機会マップ
第11章 参考文献と調査手法
- 参考文献
- 調査手法
- 出版社について
Global Atrial Fibrillation Market is estimated to be valued at US$ 26.43 Bn in 2025 and is expected to reach US$ 43.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | US$ 26.43 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.40% | 2032 Value Projection: | US$ 43.57 Bn |
Atrial fibrillation is the most common cardiac arrhythmia globally and the prevalence of diagnosed cases is growing rapidly. Rising geriatric population, increasing incidence of cardiovascular & lifestyle diseases, growth in invasive cardiac procedures, and technological advancements in diagnostic and treatment devices are some of the key factors fueling the growth of this market. However, risk of thromboembolism associated with atrial fibrillation diagnosis and treatment and lack of awareness about atrial fibrillation in developing countries are expected to hamper market growth.
Market Dynamics:
The key drivers propelling the growth of global atrial fibrillation market are rapid growth in geriatric population who are more susceptible to atrial fibrillation, rising prevalence of obesity and hypertension, increasing consumption of alcohol and tobacco, and growing number of invasive cardiac surgeries. However, high risk of thromboembolism associated with atrial fibrillation diagnosis and treatment and lack of awareness about atrial fibrillation in developing countries are projected to hinder the market growth. Growing research on development of novel ablation technologies and emergence of start-up companies offering innovative solutions present significant opportunities in the coming years.
Key Features of the Study:
This report provides in-depth analysis of the global atrial fibrillation market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global atrial fibrillation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, AtriCure, Inc., Sanofi, Bayer AG, Gilead Sciences, Inc., Amgen Inc., Merck & Co., Inc., St. Jude Medical, Inc., and Cardiovascular Systems, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global atrial fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atrial fibrillation market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Paroxysmal Atrial Fibrillation
- Persistent Atrial Fibrillation
- Permanent Atrial Fibrillation
- Treatment Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmacological Treatments
- Anticoagulants
- Antiarrhythmic Drugs
- Non-Pharmacological Treatments
- Catheter Ablation
- Surgical Procedures
- Implantable Devices
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Radiofrequency
- Laser
- Cryotherapy
- Others
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Cardiac Centers
- Home Care Settings
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Johnson & Johnson
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- AtriCure, Inc.
- Sanofi
- Bayer AG
- Gilead Sciences, Inc.
- Amgen Inc.
- Merck & Co., Inc.
- Jude Medical, Inc.
- Cardiovascular Systems, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Atrial Fibrillation Market, By Type
- Global Atrial Fibrillation Market, By Treatment
- Global Atrial Fibrillation Market, By Technology
- Global Atrial Fibrillation Market, By End User
- Global Atrial Fibrillation Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Atrial Fibrillation Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Paroxysmal Atrial Fibrillation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Persistent Atrial Fibrillation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Permanent Atrial Fibrillation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Atrial Fibrillation Market, By Treatment, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmacological Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Anticoagulants
- Antiarrhythmic Drugs
- Non-Pharmacological Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Catheter Ablation
- Surgical Procedures
- Implantable Devices
6. Global Atrial Fibrillation Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Radiofrequency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Laser
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cryotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Atrial Fibrillation Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiac Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Atrial Fibrillation Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AtriCure, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Bayer AG
- Gilead Sciences, Inc.
- Amgen Inc.
- Merck & Co., Inc.
- Jude Medical, Inc.
- Cardiovascular Systems, Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
